Australia markets close in 3 hours 4 minutes

Beximco Pharmaceuticals Limited (BXP.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
36.500.00 (0.00%)
At close: 01:40PM BST

Beximco Pharmaceuticals Limited

19 Dhanmondi R/A
Road No. 7
Dhaka 1205
Bangladesh
880 2 5861 1001
https://www.beximcopharma.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees5,700

Key executives

NameTitlePayExercisedYear born
Mr. Mohammad Ali NawazChief Financial OfficerN/AN/AN/A
Mr. S. M. Rabbur RezaChief Operating OfficerN/AN/AN/A
Mr. Jamal Ahmed ChoudhuryDirector of Accounts & FinanceN/AN/AN/A
Mr. Rizvi Ul KabirDirector of MarketingN/AN/AN/A
Mr. M. A. Arshad BhuiyanGeneral Manager of Human ResourcesN/AN/AN/A
Mr. Zakaria Seraj ChowdhuryHead of Distribution Services & Director of International MarketingN/AN/AN/A
Mr. Mohammad Asad Ullah FCSCompany Secretary & Executive DirectorN/AN/AN/A
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.

Corporate governance

Beximco Pharmaceuticals Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.